Semorinemab in Mild to Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain. Edland SD, Ucsd, Llibre-Guerra JJ. Neurology 2023 Aug 29:10.1212/WNL.0000000000207861.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Edland SD, Ucsd, Llibre-Guerra JJ. Semorinemab in Mild to Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain. Neurology 2023 Aug 29:10.1212/WNL.0000000000207861.
PMID: 37643886